Combined oxidative phosphorylation defect type 2 is a rare mitochondrial disorder due to a defect in mitochondrial protein synthesis characterized by severe intrauterine growth retardation, neonatal limb edema and redundant skin on the neck (hydrops), developmental brain defects (corpus callosum agenesis, ventriculomegaly), brachydactyly, dysmorphic facial features with low set ears, severe intractable neonatal lactic acidosis with lethargy, hypotonia, absent spontaneous movements and fatal outcome. Markedly decreased activity of complex I, II + III and IV in muscle and liver have been determined.
Comprehensive, easy-to-understand information about this condition
Checking for content...
severe X-linked mitochondrial encephalomyopathy
MONDO:0010437
hepatoencephalopathy due to combined oxidative phosphorylation defect type 1
MONDO:0012191
fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3
MONDO:0012512
combined oxidative phosphorylation defect type 4
MONDO:0012534
hypotonia with lactic acidemia and hyperammonemia
MONDO:0012718
combined oxidative phosphorylation defect type 7
MONDO:0013306